Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Eli Lilly & Co (LLY)  
$909.04 7.78 (0.86%) as of 4:30 Thu 6/27


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 956,580,000
Market Cap: 869.57(B)
Last Volume: 1,947,382 Avg Vol: 3,268,697
52 Week Range: $434.7 - $909.04
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  720
Guru Rank Value     : 1.4
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 656
Total Buy Value $0 $0 $0 $199,549
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 1,520,577 2,391,327 3,815,444 6,318,238
Total Sell Value $1,284,658,855 $1,892,909,435 $2,147,483,647 $2,147,483,647
Total People Sold 3 3 4 6
Total Sell Transactions 18 31 51 93
End Date 2024-03-30 2023-12-28 2023-06-29 2022-06-29

   
Records found: 1436
  Page 36 of 58  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Fyrwald J Erik Director   –       •      –    2018-04-16 4 A $80.12 $5,448 D/D 68 58,776     -
   Alvarez Ralph Director   –       •      –    2018-04-16 4 A $80.12 $10,896 D/D 136 40,322     -
   Luciano Juan R Director   –       •      –    2018-04-16 4 A $80.12 $9,695 D/D 121 5,835     -
   Mahony Susan SVP & Pres., Lilly Oncology   •       –      –    2018-04-16 4 AS $80.08 $1,391,710 D/D (17,379) 28,273     -
   Mahony Susan SVP & Pres., Lilly Oncology   •       –      –    2018-04-13 4 AS $80.14 $413,923 D/D (5,165) 45,652     -
   Fyrwald J Erik Director   –       •      –    2018-03-19 4 A $78.57 $5,421 D/D 69 58,708     -
   Luciano Juan R Director   –       •      –    2018-03-19 4 A $78.57 $9,664 D/D 123 5,714     -
   Alvarez Ralph Director   –       •      –    2018-03-19 4 A $78.57 $10,921 D/D 139 40,186     -
   Smiley Joshua L SVP and CFO   •       –      –    2018-03-16 4 AS $79.20 $237,600 D/D (3,000) 20,029     -
   Zakrowski Donald A Chief Accounting Officer   •       –      –    2018-03-01 4 S $76.50 $65,790 I/I (860) 1,637     -
   Zakrowski Donald A Chief Accounting Officer   •       –      –    2018-02-21 4 S $77.55 $67,934 I/I (876) 2,472     -
   Luciano Juan R Director   –       •      –    2018-02-20 4 A $77.55 $9,694 D/D 125 5,553     -
   Alvarez Ralph Director   –       •      –    2018-02-20 4 A $77.55 $10,935 D/D 141 39,768     -
   Fyrwald J Erik Director   –       •      –    2018-02-20 4 A $77.55 $5,429 D/D 70 58,229     -
   Norton Johna Senior VP, Global Quality   •       –      –    2018-02-16 4 D $78.02 $1,092 I/I (14) 34     -
   Norton Johna Senior VP, Global Quality   •       –      –    2018-02-16 4 OE $0.00 $0 I/I 48 48     -
   Zakrowski Donald A Chief Accounting Officer   •       –      –    2018-02-05 4 S $81.09 $72,981 D/D (900) 4,130     -
   Simmons Jeffrey N SVP&Pres. Elanco Animal Health   •       –      –    2018-02-05 4 AS $81.12 $780,780 D/D (9,625) 133,201     -
   Oneill Myles SVP & Pres., Mfg. Operations   •       –      –    2018-02-01 4 D $81.45 $348,606 I/I (4,280) 75,954     -
   Oneill Myles SVP & Pres., Mfg. Operations   •       –      –    2018-02-01 4 OE $0.00 $0 I/I 9,596 80,234     -
   Harrington Michael J Senior VP and General Counsel   •       –      –    2018-02-01 4 D $81.45 $880,556 D/D (10,811) 91,927     -
   Harrington Michael J Senior VP and General Counsel   •       –      –    2018-02-01 4 OE $0.00 $0 D/D 24,524 102,738     -
   Barnes Melissa S Chief Eth/Cmpl Ofcr & SVP, ERM   •       –      –    2018-02-01 4 D $81.45 $227,164 D/D (2,789) 19,318     -
   Barnes Melissa S Chief Eth/Cmpl Ofcr & SVP, ERM   •       –      –    2018-02-01 4 OE $0.00 $0 D/D 6,398 22,107     -
   Simmons Jeffrey N SVP&Pres. Elanco Animal Health   •       –      –    2018-02-01 4 D $81.45 $756,996 D/D (9,294) 142,826     -
  1436 Records found
  Previous  30  31  32  33  34  35  36  37  38  39  Next   
  Page 36 of 58
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us